Methuselah Medical Service Inc is categorized under Family Practice Doctors in New Rochelle, NY and active since 1998.
Methuselah Medical Service Inc was established in 1998, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Family Practice Doctors business, which does work in the B2C market, and is classified as a Family Practice Doctors, under code number 621111 by the NAICS.
If you are seeking more information, feel free to contact Ralph Essien at the company’s single location by writing to 25 Coligni Avenue, New Rochelle, New York NY 10801 or by phoning (914) 636-1967. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Methuselah Medical Service Inc |
| Contact Person: | Ralph Essien |
| Address: | 25 Coligni Avenue, New Rochelle, New York 10801 |
| Phone Number: | (914) 636-1967 |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 1998 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Family Practice Doctors |
| SIC Code: | 8011 |
| NAICS Code: | 621111 |
| Share This Business: |
Methuselah Medical Service Inc was started in 1998 to provide professional Family Practice Doctors under the SIC code 8011 and NAICS code 621111. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Ralph Essien for inquiries that concern Methuselah Medical Service Inc by calling the company number (914) 636-1967, as your correspondence is most welcome. Additionally, the physical location of the single location of Methuselah Medical Service Inc can be found at the coordinates 40.921111,-73.788588 as well as the street address 25 Coligni Avenue in New Rochelle, New York 10801.
For its online presence, you may visit Methuselah Medical Service Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.